Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy

PURPOSE: In malignant tumors, predictive markers have been developed with respect to targeted therapies. One of the first targeted therapies was the hormone-blocking treatment of tumors of the male and female reproductive system. A typical therapy in breast cancer is the use of the selective estroge...

Descripción completa

Detalles Bibliográficos
Autores principales: Pachmann, Katharina, Camara, Oumar, Kohlhase, Annika, Rabenstein, Carola, Kroll, Torsten, Runnebaum, Ingo B., Hoeffken, Klaus
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074080/
https://www.ncbi.nlm.nih.gov/pubmed/20694797
http://dx.doi.org/10.1007/s00432-010-0942-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074080/
https://www.ncbi.nlm.nih.gov/pubmed/20694797
http://dx.doi.org/10.1007/s00432-010-0942-4

Ejemplares similares